NCT01513525View on ClinicalTrials.gov

Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

DiabetesHealthy

Interventions

DRUG

liraglutide

Single dose of 0.60 mg administered subcutaneously in three different injection sites on three separate dosing visits

Trial Locations (1)

41460

Novo Nordisk Investigational Site, Neuss

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY